Home › Multiple Myeloma › Michigan › Warren
Multiple Myeloma clinical trials in Warren, MI
4 studies for Multiple Myeloma are looking for participants at sites in and around Warren (within about 30 miles). Open a study to see who can join and how to contact the study team.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Henry Ford Health Warren Hospital, Warren
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Henry Ford Health Warren Hospital, Warren
- Henry Ford Madison Heights Hospital - Breast, Warren
- Henry Ford Warren Hospital - GLCMS, Warren
- and 3 more
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Advanced Breast Care Center PLLC, Warren
- Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren
- Macomb Hematology Oncology PC, Warren
- and 4 more
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
RecruitingPhase 3
- Henry Ford St. John Hospital, Grosse Pointe Woods · 6 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Rochester, MN23 studies
- Washington, DC22 studies
Other studies in Warren
- Breast Cancer9 studies
- Prostate Cancer7 studies
- Lung Cancer6 studies
- Coronary Artery Disease5 studies
- Colorectal Cancer5 studies
- Bladder Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
- Aortic Valve Stenosis4 studies
- Sjogren's Syndrome3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Post-COVID Conditions (Long COVID)3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.